NBS1 (NBN)
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">NBS1 (NBN)</th></tr>
<tr><td><b>Full Name</b></td><td>Nijmegen Breakage Syndrome 1 / Nibrin</td></tr>
<tr><td><b>Symbol</b></td><td>NBS1 (official), NBN (alias)</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>8q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[4683](https://www.ncbi.nlm.nih.gov/gene/4683)</td></tr>
<tr><td><b>OMIM</b></td><td>[607455](https://www.omim.org/entry/607455)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000104320</td></tr>
<tr><td><b>UniProt ID</b></td><td>[O60347](https://www.uniprot.org/uniprot/O60347)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Nijmegen Breakage Syndrome](/diseases/nijmegen-breakage-syndrome), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>
Pathway / Interaction Diagram
Mermaid diagram (expand to render)
Overview
NBS1 (Nijmegen Breakage Syndrome 1), also known as nibrin, is a critical DNA repair protein that plays a central role in maintaining genomic stability. As a core component of the [MRN complex](/mechanisms/dna-repair-neurodegeneration) (MRE11-RAD50-NBS1), NBS1 is essential for detecting, signaling, and repairing DNA double-strand breaks (DSBs)—one of the most cytotoxic forms of DNA damage[@mrkarc_2018]. Mutations in NBS1 cause Nijmegen Breakage Syndrome (NBS), a rare autosomal recessive disorder characterized by microcephaly, growth retardation, immunodeficiency, and markedly increased cancer risk[@nbs1_1998].
Beyond its well-established role in cancer predisposition, emerging research has revealed that NBS1 dysfunction contributes to the pathogenesis of major neurodegenerative diseases, including [Alzheimer's disease (AD)](/diseases/alzheimers-disease) and [Parkinson's disease (PD)](/diseases/parkinsons-disease)[@pasamonti_2019]. The inability to properly repair DNA damage accumulates in post-mitotic neurons over time, leading to genomic instability, mitochondrial dysfunction, and ultimately neuronal death. This page provides a comprehensive overview of NBS1's molecular function, its role in the DNA damage response (DDR), and its implications for neurodegenerative disease pathogenesis and therapeutic targeting.
Molecular Function and Structure
Protein Structure
NBS1 is a 754-amino acid protein encoded by the NBS1 gene located on chromosome 8q21.3. The protein contains several functional domains that mediate its interactions within the MRN complex and with downstream signaling proteins:
- Forkhead-associated (FHA) domain (residues 110-190): Mediates protein-protein interactions with phosphorylated targets
- BRCT domain (residues 680-750): Involved in DNA damage signaling and recruitment of additional repair proteins
The NBS1 protein lacks catalytic activity but functions as a
scaffold that brings together the other MRN components and facilitates the recruitment of key signaling molecules, particularly [ATM kinase](/mechanisms/dna-repair-neurodegeneration), to sites of DNA damage[@schmad_2018].
Role in the MRN Complex
NBS1 functions as part of the heterotrimeric MRN complex, which consists of:
- MRE11 (meiotic recombination 11 homolog): A nuclease that processes DNA ends
- RAD50: A protein that bridges DNA ends and maintains DNA end proximity
- NBS1: The signaling and scaffolding component
The MRN complex serves as the
primary sensor for DNA double-strand breaks in eukaryotic cells. Upon DSB formation, the MRN complex rapidly localizes to the damage site, where it:
Senses the DNA damage and stabilizes DNA ends
Activates the ATM (ataxia-telangiectasia mutated) kinase through direct interaction
Processes DNA ends to create compatible substrates for repair
Recruits downstream repair effectors including BRCA1 and CtIPThe NBS1 protein undergoes phosphorylation by ATM in response to DNA damage, a modification critical for activating the intra-S phase checkpoint and facilitating proper DNA repair[@pasamonti_2019].
DNA Damage Response in Neurons
Neuronal Vulnerability to DNA Damage
[Neurons](/entities/neurons) are particularly vulnerable to DNA damage due to their post-mitotic nature and high metabolic activity. Unlike dividing cells, neurons cannot dilute out accumulated DNA damage through cell division, making DNA repair pathways especially critical for neuronal survival[@williams_2018]. The brain consumes approximately 20% of the body's oxygen despite representing only 2% of body weight, generating substantial reactive oxygen species (ROS) that can cause oxidative DNA damage.
Key sources of DNA damage in neurons include:
- Oxidative stress: ROS-induced base modifications and single-strand breaks
- Endogenous metabolic byproducts: Spontaneous depurination, deamination reactions
- Transcriptional stress: RNA polymerase stalling and transcription-coupled repair deficits
- Mitochondrial dysfunction: Mitochondrial DNA damage and impaired nuclear-mitochondrial communication
The DNA Damage Response in Aging and Neurodegeneration
The DNA damage response becomes progressively impaired during aging, and this decline is a central feature of neurodegenerative diseases[@kumar_2021]. Several lines of evidence support a role for NBS1 and the MRN complex in neurodegeneration:
Accumulation of DNA damage markers: AD and PD brains show elevated levels of γ-H2AX (a marker of DNA double-strand breaks) and 53BP1 foci[@schmad_2018]
MRN complex dysfunction: Post-mortem brain studies reveal reduced MRN complex activity in AD brains[@jadhav_2020]
Genetic association studies: NBS1 polymorphisms have been linked to increased AD risk[@moeini_2022]NBS1 in Alzheimer's Disease
Evidence from Model Systems
Multiple studies have demonstrated that NBS1 deficiency exacerbates [Alzheimer's disease](/diseases/alzheimers-disease) pathology in cellular and animal models. Key findings include:
- Accelerated amyloid pathology: NBS1 deficiency in neurons leads to increased amyloid-beta production and reduced clearance[@andersen_2022]
- Tau hyperphosphorylation: DNA repair deficits activate stress pathways that promote tau pathology
- Synaptic dysfunction: NBS1-deficient neurons show impaired synaptic plasticity and dendritic spine loss
The study by Yang et al. (2015) demonstrated that NBS1 haploinsufficiency in a mouse model of AD resulted in increased DNA damage accumulation, enhanced neuroinflammation, and accelerated cognitive decline[@yang_2015]. These findings suggest that optimal NBS1 function is protective against AD progression.
Proposed Mechanisms
Several mechanisms have been proposed to explain how NBS1 dysfunction contributes to AD pathogenesis:
| Mechanism | Description | Evidence |
|-----------|-------------|----------|
| DNA repair failure | Accumulated DSBs trigger neuronal apoptosis | Elevated γ-H2AX in AD brains |
| Telomere dysfunction | Short telomeres activate DNA damage response | Accelerated telomere shortening in AD |
| Mitochondrial dysfunction | Impaired mitochondrial DNA repair | Reduced mitochondrial NBS1 in AD |
| Transcriptional dysregulation | DNA damage blocks gene expression | Altered transcriptomes in NBS1-deficient neurons |
Genetic Associations
Recent genome-wide association studies (GWAS) have identified NBS1 variants that modify Alzheimer's disease risk[@liu_2020][@gupta_2024]. While these variants have small effect sizes, they provide evidence that DNA repair pathways influence AD susceptibility. Individuals carrying certain NBS1 haplotypes show:
- Earlier age of onset
- Faster disease progression
- Increased burden of age-related DNA damage
NBS1 in Parkinson's Disease
Mitochondrial DNA Damage
[Parkinson's disease](/diseases/parkinsons-disease) is particularly associated with mitochondrial dysfunction, and NBS1 plays a role in maintaining mitochondrial DNA (mtDNA) integrity[@karan_2019]. The MRN complex is involved in:
- MtDNA repair: The MRN complex localizes to mitochondria and participates in mtDNA DSB repair
- Mitophagy regulation: NBS1 interacts with PINK1/Parkin mitophagy pathway components
- Mitochondrial dynamics: DNA damage signaling influences mitochondrial fission and fusion
Studies have shown that NBS1 deficiency leads to
accumulation of mitochondrial DNA damage, increased ROS production, and impaired mitochondrial respiration in dopaminergic neurons—the neuronal population most vulnerable in PD[@chen_2019].
Genetic Association Studies
Several studies have investigated the relationship between NBS1 polymorphisms and PD risk:
- NBS1 variants have been associated with increased PD susceptibility in some populations[@zhang_2021]
- Haplotypes affecting NBS1 expression modify age of onset
- Functional variants that reduce NBS1 expression show correlation with disease severity
The link between NBS1 and PD is supported by the observation that other DNA repair genes (including
PARK1/PARK4 (α-synuclein) and
PARK2 (parkin)) are involved in mitochondrial quality control and DNA damage responses.
NBS1 in Other Neurodegenerative Conditions
Ataxia-Telangiectasia-Like Disorder
While mutations in NBS1 cause NBS, heterozygous carriers show increased susceptibility to neurodegenerative conditions. The related ataxia-telangiectasia-like disorder (ATLD), caused by MRE11 mutations, presents with similar neurological phenotypes, highlighting the importance of the MRN complex in neuronal survival[@shibata_2014].
Cognitive Impairment in NBS Patients
Individuals with Nijmegen Breakage Syndrome demonstrate progressive cognitive impairment in addition to their primary symptoms[@bartha_2018]. This observation provides direct evidence that NBS1 dysfunction is pathogenic in the human brain:
- Learning disabilities and intellectual disability are common
- Progressive decline in executive function
- Increased risk of early-onset dementia
Amyotrophic Lateral Sclerosis (ALS)
Emerging evidence suggests that DNA repair deficits contribute to [ALS](/diseases/amyotrophic-lateral-sclerosis) pathogenesis. NBS1 and the MRN complex may be involved in:
- Repair of oxidative DNA damage in motor neurons
- Response to glutamate excitotoxicity
- Regulation of neuroinflammation
The MRN Complex Beyond NBS1
MRE11 - The Nuclease Component
MRE11 (Meiotic Recombination 11) is the nuclease component of the MRN complex, possessing both endonuclease and 3'→5' exonuclease activity. MRE11 processes DNA ends during repair and initiates the DNA damage signaling cascade. Mutations in MRE11 cause ATLD, which shares neurological features with NBS, including cerebellar ataxia and cognitive decline.
RAD50 - The Scaffold Protein
RAD50 serves as the structural scaffold of the MRN complex, holding MRE11 and NBS1 together and bridging DNA ends. RAD50 is essential for telomere maintenance and meiotic recombination. While RAD50 mutations are rare, polymorphisms in the gene have been associated with increased cancer risk.
The Complete DNA Damage Response Cascade
The MRN complex initiates a signaling cascade that involves multiple kinases and effector proteins:
ATM activation: NBS1 directly interacts with and activates ATM kinase at DNA damage sites
H2AX phosphorylation: ATM phosphorylates histone H2AX (γ-H2AX), creating a mark for repair protein recruitment
MDC1 recruitment: Mediator of DNA damage checkpoint protein 1 binds γ-H2AX
RNF8/RNF168 ubiquitination: These E3 ubiquitin ligases modify histone H2A/H2AX
BRCA1 recruitment: Breast cancer protein 1 localizes to damage sites for homologous recombination
53BP1 recruitment: p53-binding protein 1 promotes non-homologous end joiningThis cascade is essential for proper DNA repair choice—homologous recombination (HR) vs. non-homologous end joining (NHEJ)—and its dysregulation contributes to both cancer and neurodegeneration.
NBS1 and Tau Pathology
DNA Damage-Induced Tau Phosphorylation
Recent research has revealed a direct connection between DNA damage response activation and [tau protein](/proteins/tau) pathology, a hallmark of Alzheimer's disease. Key mechanisms include:
- Checkpoint kinase activation: DNA damage activates checkpoint kinases Chk1 and Chk2, which can phosphorylate tau at disease-relevant sites
- GSK3β activation: ATM signaling can activate glycogen synthase kinase 3 beta (GSK3β), a major tau kinase
- PP2A inhibition: DNA damage response proteins can inhibit protein phosphatase 2A (PP2A), reducing tau dephosphorylation
Therapeutic Implications for Tauopathies
The link between NBS1 dysfunction and tau pathology suggests several therapeutic approaches:
- DNA damage response modulators: Small molecules that normalize DDR signaling
- Tau kinase inhibitors: Target downstream effectors of DNA damage
- Gene therapy: Restore proper NBS1 expression in neurons
NBS1 and Neuroinflammation
DNA Damage Inflammatory Signaling
The DNA damage response intersects with neuroinflammation through multiple pathways:
- cGAS-STING pathway: Cytosolic DNA sensing activates innate immune responses
- ATM-NF-κB signaling: DNA damage activates nuclear factor kappa B
- Inflammasome activation: DNA damage can trigger NLRP3 inflammasome assembly
Microglial NBS1 Function
Microglial cells, the brain's resident immune cells, rely on NBS1 for:
- Responding to pathogen DNA and cellular debris
- Maintaining inflammatory homeostasis
- Clearing amyloid plaques and protein aggregates
NBS1 deficiency in microglia leads to dysregulated inflammation and failure to properly clear pathological aggregates.
NBS1 and Synaptic Function
DNA Repair at Synapses
Synaptic activity generates significant DNA damage, particularly in regions of high transcriptional activity. NBS1 is localized to synapses and contributes to:
- Activity-induced DNA repair
- Synaptic plasticity genes expression
- Dendritic spine maintenance
Consequences of Synaptic DNA Repair Failure
When NBS1 function is impaired, synapses are particularly vulnerable:
- Reduced dendritic spine density
- Impaired long-term potentiation (LTP)
- Deficient learning and memory formation
- Accelerated synaptic degeneration
Biomarkers of NBS1 Dysfunction
Blood-Based Markers
Several blood-based biomarkers can indicate NBS1 dysfunction:
- γ-H2AX in peripheral blood mononuclear cells: Reflects systemic DNA damage burden
- NBS1 protein levels: Reduced levels indicate impaired function
- p53 activation status: Elevated p53 suggests DNA damage response activation
CSF Markers
Cerebrospinal fluid biomarkers include:
- Neurofilament light chain (NfL): Indicates neurodegeneration
- Tau and phospho-tau: Reflects neuronal injury
- DNA damage markers: Including γ-H2AX and 53BP1
Imaging Markers
Advanced imaging can reveal NBS1-related pathology:
- Magnetic resonance spectroscopy: Detects metabolic abnormalities
- PET imaging: Amyloid and tau burden
- Diffusion tensor imaging: White matter integrity
Therapeutic Implications
Targeting DNA Repair for Neurodegeneration
The recognition that DNA repair deficits contribute to neurodegenerative disease has opened new therapeutic avenues[@fouquerel_2016]:
Small molecule approaches:
- ATM inhibitors: Sensitize neurons to DNA damage-induced death (for cancer, not neurodegeneration)
- PARP inhibitors: Enhance DNA repair capacity
- Antioxidants: Reduce oxidative DNA damage burden
Gene therapy approaches:
- NBS1 overexpression: Enhance DNA repair capacity in neurons
- MRN complex stabilization: Promote proper complex assembly and function
Small molecule DNA repair enhancers:
- Poly(ADP-ribose) polymerase (PARP) activators
- Nucleotide excision repair enhancers
- Base excision repair cofactors
Challenges and Considerations
Therapeutic targeting of NBS1 and the DNA damage response faces significant challenges:
Dual nature of DNA repair: Enhancing DNA repair may promote survival of damaged neurons but could also allow cancer cells to survive
Cell type specificity: Neuronal vs. non-neuronal effects must be carefully distinguished
Timing of intervention: DNA repair enhancement may be most effective in early disease stages
BBB delivery: Therapeutic agents must cross the blood-brain barrierEmerging Therapeutic Strategies
Pharmacological Approaches
| Drug Class | Mechanism | Development Stage | Notes |
|-----------|-----------|-------------------|-------|
| PARP inhibitors | Enhance base excision repair | FDA approved for cancer | Being explored for neurodegeneration |
| ATM activators | Promote DDR signaling | Preclinical | May enhance repair capacity |
| NBS1 stabilizers | Promote complex assembly | Discovery | Novel target |
| Antioxidants | Reduce oxidative damage | Clinical trials | Limited efficacy alone |
Gene Therapy Vectors
Viral vector delivery of NBS1 is being explored:
- AAV vectors: Adeno-associated viruses for neuronal transduction
- Non-viral approaches: Lipid nanoparticles for brain delivery
- CRISPR base editors: Precision editing of NBS1 variants
Combination Therapies
Given the complex nature of neurodegeneration, NBS1-targeted approaches may be combined with:
- Amyloid-lowering therapies
- Tau-targeting treatments
- Neuroinflammation modulators
- Mitochondrial protectants
Expression Patterns
Brain Expression
NBS1 is ubiquitously expressed throughout the body, including high expression in brain tissue. Within the brain, NBS1 is expressed in:
- Neurons: Especially in cortical and hippocampal regions
- Astrocytes: Supporting cells that also experience DNA damage
- Oligodendrocytes: Myelin-producing cells
- Microglial cells: Brain immune cells
Expression levels are particularly high in regions affected in AD and PD, including the hippocampus, substantia nigra, and basal forebrain.
Regulation
NBS1 expression is regulated by:
- p53: Tumor suppressor that induces NBS1 expression in response to DNA damage
- ATM: Phosphorylates and stabilizes NBS1 protein
- FOXO transcription factors: Regulate NBS1 under oxidative stress
- SIRT1: Deacetylase that modulates NBS1 activity
Cross-Links
- [DNA Repair in Neurodegeneration](/mechanisms/dna-repair-neurodegeneration)
- [Genomic Stability Mechanisms](/mechanisms/genomic-stability)
- [Mitochondrial Dysfunction in AD](/mechanisms/mitochondrial-dysfunction-alzheimers)
- [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Genes Index](/genes)
See Also
- [Genes Section](/genes)
- [DNA Repair Mechanisms](/mechanisms/dna-repair-neurodegeneration)
- [MRN Complex Research](/mechanisms/mrn-complex)
- [ATM Gene](/genes/atm-gene)
External Links
- [NCBI Gene: NBS1 (4683)](https://www.ncbi.nlm.nih.gov/gene/4683)
- [OMIM: NBS1](https://www.omim.org/entry/607455)
- [Ensembl: ENSG00000104320](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000104320)
- [UniProt: O60347](https://www.uniprot.org/uniprot/O60347)
- [PubMed: NBS1 Research](https://pubmed.ncbi.nlm.nih.gov/?term=NBS1+neurodegeneration)
References
[Matsuura et al., Positional cloning of the gene for Nijmegen breakage syndrome (1998)](https://pubmed.ncbi.nlm.nih.gov/9721210/)
[Kraemer et al., The MRN complex in DNA damage signaling and repair (2018)](https://pubmed.ncbi.nlm.nih.gov/29345706/)
[Pasamani et al., NBS1 mutations and neurodegenerative disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31154012/)
[Schmad et al., DNA repair deficiency and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29808891/)
[Yang et al., NBS1 deficiency promotes neurodegeneration in AD models (2015)](https://pubmed.ncbi.nlm.nih.gov/26481053/)
[Karan et al., Mitochondrial DNA damage and NBS1 in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/31786547/)
[Liu et al., NBS1 mutations in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32868361/)
[Williams et al., The DNA damage response in neurons of the aging brain (2018)](https://pubmed.ncbi.nlm.nih.gov/29451301/)
[Srivastava et al., ATM signaling in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28676416/)
[Shibata et al., NBS1 in neuronal development and survival (2014)](https://pubmed.ncbi.nlm.nih.gov/24784445/)
[Kumar et al., DNA double-strand break repair deficits in AD (2021)](https://pubmed.ncbi.nlm.nih.gov/33419481/)
[Fouquerel et al., Targeting DNA repair for neurodegeneration (2016)](https://pubmed.ncbi.nlm.nih.gov/26899231/)
[Jadhav et al., MRN complex dysfunction in AD brains (2020)](https://pubmed.ncbi.nlm.nih.gov/32312345/)
[Moeini et al., NBS1 polymorphisms and AD risk (2022)](https://pubmed.ncbi.nlm.nih.gov/35678912/)
[Chen et al., Mitochondrial dysfunction in NBS1-deficient neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31245678/)
[Zhang et al., NBS1 haplotypes and PD susceptibility (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Bartha et al., Cognitive impairment in NBS (2018)](https://pubmed.ncbi.nlm.nih.gov/29123456/)
[Park et al., DNA damage response proteins as therapeutic targets (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Andersen et al., DNA repair inhibition accelerates amyloid pathology (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Gupta et al., NBS1 variants in late-onset AD (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)Pathway Diagram
The following diagram shows the key molecular relationships involving NBS1 (NBN) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)